Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

This publication has 36 references indexed in Scilit:

• Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
  Journal of Clinical Investigation, 1997
• Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-κB Survival Pathway
  Experimental Cell Research, 1997
• Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival
  Journal of Neuro-Oncology, 1997
• Prognostic Significance of p53 Immunoreactivity in Adult Patients with Supratentorial Fibrillary Astrocytic Neoplasms
  Diagnostic Molecular Pathology, 1994
• A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
  Proceedings of the National Academy of Sciences, 1994
• Function and Activation of NF-kappaB in the Immune System
  Annual Review of Immunology, 1994
• The future of therapy for glioblastoma
  Surgical Neurology, 1993
• Radiosurgery as part of the initial management of patients with malignant gliomas.
  Journal of Clinical Oncology, 1992
• Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours
  British Journal of Cancer, 1992
• Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
  Cell, 1991